CCL5 and hepatocellular carcinoma: In an independent HCC cohort (validation cohort 1, n = 27), CCL5+ CTCs were detected in 13 out of 27 patients (48%), and 27 out of 41 CTCs (66%) were CCL5 positive (Supplementary Fig. 4b).